Genpact (NYSE:G – Free Report) had its target price trimmed by Needham & Company LLC from $50.00 to $45.00 in a research report report published on Friday morning, MarketBeat reports. The firm currently has a buy rating on the business services provider’s stock.
Several other research analysts have also recently weighed in on G. Robert W. Baird decreased their price target on Genpact from $45.00 to $38.00 and set a “neutral” rating for the company in a research note on Tuesday, July 7th. Susquehanna dropped their price objective on Genpact from $42.00 to $37.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. TD Cowen reduced their price objective on Genpact from $47.00 to $42.00 and set a “buy” rating for the company in a report on Thursday, July 9th. Weiss Ratings lowered Genpact from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, June 24th. Finally, Mizuho lowered their target price on shares of Genpact from $49.00 to $39.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Two analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Genpact has a consensus rating of “Hold” and an average target price of $39.33.
Check Out Our Latest Research Report on G
Genpact Price Performance
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings data on Tuesday, June 30th. The business services provider reported $1.00 earnings per share for the quarter. The company had revenue of $1.34 billion during the quarter. Genpact had a net margin of 11.04% and a return on equity of 23.53%. As a group, equities research analysts anticipate that Genpact will post 3.64 earnings per share for the current fiscal year.
Genpact Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 24th. Stockholders of record on Thursday, September 10th will be paid a $0.1875 dividend. This represents a $0.75 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Thursday, September 10th. Genpact’s dividend payout ratio (DPR) is 23.01%.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the company. Osbon Capital Management LLC bought a new stake in shares of Genpact during the 4th quarter valued at about $25,000. V Square Quantitative Management LLC purchased a new stake in shares of Genpact during the 4th quarter valued at about $30,000. iSAM Funds UK Ltd purchased a new stake in shares of Genpact during the 3rd quarter valued at about $29,000. Johnson Financial Group Inc. bought a new position in shares of Genpact in the 3rd quarter worth approximately $29,000. Finally, Larson Financial Group LLC lifted its stake in shares of Genpact by 428.4% in the 4th quarter. Larson Financial Group LLC now owns 708 shares of the business services provider’s stock worth $33,000 after purchasing an additional 574 shares during the period. Institutional investors own 96.03% of the company’s stock.
Genpact News Roundup
Here are the key news stories impacting Genpact this week:
- Positive Sentiment: Strong Q2 earnings and revenue: Genpact reported adjusted earnings of $1.00 per share, ahead of the $0.97 consensus estimate, while revenue reached $1.34 billion versus expectations of $1.33 billion. Revenue increased 7.1% year over year, and earnings rose from $0.88 per share a year earlier. Genpact Q2 Earnings and Revenues Top Estimates
- Positive Sentiment: Advanced Technology Solutions accelerated: The division’s revenue grew 24.1% year over year and was identified as the primary driver of quarterly performance, supporting management’s transition toward “Agentic Operations.” Genpact Reports Second Quarter 2026 Results
- Positive Sentiment: Outlook improved: Genpact raised its fiscal 2026 adjusted earnings-growth outlook and provided full-year EPS guidance of approximately $4.09, above the $3.99 analyst consensus. Third-quarter EPS guidance of $1.04–$1.05 also exceeds the $1.03 consensus estimate.
- Positive Sentiment: JPMorgan raised its price target to $45 from $40, while maintaining a Neutral rating, indicating potential upside based on the cited reference price. JPMorgan Genpact Price Target Update
- Neutral Sentiment: Analyst views remain mixed: Susquehanna increased its target to $37 from $33 but retained a Neutral rating, while the broader brokerage consensus remains Hold. Genpact Analyst Ratings
- Negative Sentiment: Needham reduced its price target to $45 from $50, although it maintained a Buy rating. The target cut may be weighing on sentiment despite the company’s stronger results. Needham Genpact Price Target Update
About Genpact
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Recommended Stories
- Five stocks we like better than Genpact
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
